Dupont Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,941
Closed -$191K 1160
2022
Q4
$191K Sell
3,941
-3,775
-49% -$237K 0.01% 802
2022
Q3
$544K Sell
7,716
-2,062
-21% -$176K 0.03% 585
2022
Q2
$694K Buy
9,778
+1,092
+13% +$70.4K 0.03% 598
2022
Q1
$694K Buy
8,686
+6,604
+317% +$492K 0.03% 638
2021
Q4
$190K Sell
2,082
-1,496
-42% -$161K 0.01% 1140
2021
Q3
$460K Buy
3,578
+253
+8% +$35.4K 0.01% 927
2021
Q2
$507K Hold
3,325
0.01% 955
2021
Q1
$350K Sell
3,325
-683
-17% -$68.4K 0.01% 1097
2020
Q4
$318K Sell
4,008
-5,142
-56% -$376K 0.01% 1020
2020
Q3
$518K Sell
9,150
-613
-6% -$33K 0.01% 739
2020
Q2
$601K Buy
+9,763
New +$399K 0.01% 695

Other funds holding STAA

Dupont Capital Management's STAA Position: Q1 2023 in Review

Dupont Capital Management sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 3,941 shares — an estimated $191K sold.

Dupont Capital Management first reported a position in STAA in Q2 2020 and held it in 11 quarters. The position peaked at $694K in Q2 2022. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Dupont Capital Management reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 3,941 STAAR Surgical shares in Q1 2023, an estimated $191K.
  • Dupont Capital Management first reported a position in STAAR Surgical in Q2 2020 and held it in 11 quarters.
  • Dupont Capital Management's STAAR Surgical position peaked at $694K in Q2 2022.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.